Shazli Azmi

[Shazli Azmi @ShazliAzmi]

Such an amazing time catching up with everyone @Neurodiab_eu. Takk så mye @Diabeteslegen for being a fantastic host!

[ENA Group 👁️ @GroupENA]

Congratulations to Dr @ShazliAzmi for being awarded the Göran Sundkvist Young Investigators #Award for Clinical Science @Neurodiab_eu for her impressive & intense #research career on the utility of #corneal confocal #microscopy in diabetic neuropathy under @Rayazamalik mentorship

[Neurodiab @Neurodiab_eu]

Proud moment for the NEUROdiab Youth Committee!
Our first paper, born from last year’s NEUROdiab debate on whether clinical diabetic neuropathy is reversible, is now published in the journal of @PNSociety1
Special thanks to @CallaghanNeuro and Bruce Perkins for leading the debate

[Gordon Sloan @GordonSloan9]

@Neurodiab_eu @PNSociety1 @CallaghanNeuro @EASDnews @lucadonofrio88 @EidSteph @KenderZoltan @FerdousiMaryam @ShazliAzmi @VinceSpallone Super proud of this paper - thanks to all for contributing - especially @CallaghanNeuro and Bruce Perkins

[Ferrah Choudhary @FerrahChoudhary]

Join me for this year's Trans Pennine PCI meeting in Sheffield. We have a fantastic programme and faculty lined up and look forward to welcoming you. Register here: https://t.co/2hHtmQtbj3
@MillbrookMed @sanjaysastry @ammozid and Javaid Iqbal @BCIS_uk @BCSWIC

[Stéphanie Eid, PhD @EidSteph]

Another great addition to the @Neurodiab_eu Youth Committee Hallmark Papers series, featuring the influential @cochranecollab by @CallaghanNeuro @EvaFeldmanMDPhD et al. on glucose control and diabetic neuropathy
Plus an author perspective from Brian himself. Worth checking out 👇🏻

[Neurodiab @Neurodiab_eu]

Feeding and moving the nerve: a metabolic cure for neuropathy?
On Neurodiab website a signaling of articles on #diabeticneuropathy
The 224th Publication News is by Shazli Azmi (https://t.co/9LAPLr5wmQ)

[Niels Ejskjaer @NielsEjskjaer]

🇩🇰🇪🇸 Grand Finale 19th #ATTD2026.
5 Great Days of #DiabetesTechnology,
5300 delegates, 105 nations, 945 abstracts, +200 lectures, 21 industry symposia. #StenoNord proudly delivered 4 PROMS-VBHCi presentations
😊Thank you ever so much for great learnings & friendships, everybody😊

[Neurodiab @Neurodiab_eu]

The BOND study: no effect on neuropathy of one year of benfotiamine in people with type 2 diabetes and symptomatic polyneuropathy
On Neurodiab website a signaling of articles on #diabeticneuropathy
The 217th Publication News is by Maryam Ferdousi (https://t.co/z4B4SgRGeB)

[Stéphanie Eid, PhD @EidSteph]

Don’t miss tomorrow’s NEUROdiab Youth Committee Webinar on diabetic peripheral neuropathy & metabolic disorders! 🧠

Join us at 7:00 pm (GMT) and be part of the discussion !

@CallaghanNeuro @ShazliAzmi @VinceSpallone @Neurodiab_eu

[Neurodiab @Neurodiab_eu]

The 3rd free Webinar of NEUROdiab Youth Committee is on 3 March 2026 at 7:00pm (BST) (https://t.co/trLdzwThlP [https://t.co/fuwf9LU7i8])
Don’t miss the opportunity to hear from leading experts in #diabeticneuropathy how metabolic and lipid-related risk factors play a role

[Neurodiab @Neurodiab_eu]

On the 2026 International Day of Women and Girls in Science, NEUROdiab recognises the contributions of young women scientists to research and treatment of #diabeticneuropathy

[Neurodiab @Neurodiab_eu]

Diabetic neuropathies in Greenland: the role of Inuit ancestry and modernization in disease prevalence
On Neurodiab website a signaling of articles on #diabeticneuropathy
The 202nd Publication News is by Johan Røikjer (https://t.co/BIL4jreQtn)

[Neurodiab @Neurodiab_eu]

Insights into inflammation and axonal loss in human diabetic neuropathy: a real step forward
On Neurodiab website a signaling of articles on #diabeticneuropathy
The 203rd Publication News is by Stephanie Eid (https://t.co/0ippenifIX)

[Neurodiab @Neurodiab_eu]

#WorldDiabetesDay2025 is focused on "Diabetes at work"
The NEUROdiab Youth Committee is committed to addressing #diabeticneuropathy and pain to limit their impact on the well-being and improve the daily lives and work experience of people with diabetes.

[Neurodiab @Neurodiab_eu]

Beyond pain relief: systemic benefits of spinal cord stimulation in painful diabetic neuropathy
On Neurodiab website a signaling of articles on #diabeticneuropathy #neuropathicpain
The 198th Publication News is by Shazli Azmi (https://t.co/Pm9rOQauEV)

[Prof Kamlesh Khunti @kamleshkhunti]

🔥 Incretin therapies & liver outcomes in T2 diabetes

Real-world EHR study (150M+ pateints):

📉 Tirzepatide↓ risk of major adverse liver outcomes (MALO) by 47%(HR 0.53)

📉 Semaglutide↓ risk by 19% (HR 0.81)

⚪️ Liraglutide - no significant benefit

➡️ Benefit driven by ↓ compensated & decompensated cirrhosis

Exciting times

#Tirzepatide #Semaglutide #MASH #MASLD #Diabetes #LiverDisease #EndoTwitter

https://t.co/DjJWRgMwKm

[Stéphanie Eid, PhD @EidSteph]

The @Neurodiab_eu Youth Committee just met to brainstorm new initiatives. Excited about what’s coming 🚀

@ShazliAzmi @GordonSloan9 @lucadonofrio88 @KenderZoltan @FerdousiMaryam

[Shazli Azmi @ShazliAzmi]

Fab work @GordonSloan9!

[touchENDOCRINOLOGY @touchENDOCRINE]

🩺🌍 We’re proud to introduce Dr Gordon Sloan @GordonSloan9, NIHR Clinical Lecturer in Diabetes and Endocrinology at the University of Sheffield (UK), as a touchENDOCRINOLOGY Future Leader 2025.

Specialising in diabetic peripheral neuropathy (DPN) — a condition that can precede neuropathic pain and foot ulceration — Dr Sloan is committed to advancing understanding and treatment for this debilitating complication of diabetes. His research, publications, and award-winning contributions are already shaping the field.

Read more about his journey, his mentors, and his vision for improving the lives of people living with DPN.

👉 https://t.co/3U4jfneQwX

#FutureLeader2025 #DiabetesCare #DiabeticNeuropathy #DPN #Endocrinology #DiabetesResearch #ClinicalLeadership

[Shazli Azmi @ShazliAzmi]

Congratulations! Absolutely amazing!

[Muhammad Ali @MuhammadAliBox]

🥊 HISTORY MADE! 🏆

On Saturday night, I became the WBC Asia Champion, the first ever diabetic boxing champion in the world. 🌍🔥

They said it couldn’t be done. They said my condition would hold me back. But champions are built from challenges, and I refused to surrender. 💪

[Neurodiab @Neurodiab_eu]

Reading between the BOLD lines: multimodal MRI signatures of type 1 diabetic neuropathy
On Neurodiab website a signaling of articles on #diabeticneuropathy
The 195th NEUROdiab Publication News is by Jamie Burgess (https://t.co/4Uxr3wR3bo)

[Shazli Azmi @ShazliAzmi]

Didn’t get the memo about the outfit colour scheme 😀

[Neurodiab @Neurodiab_eu]

NEUROdiab thanks all speakers, chairs, and attendees of the NEUROdiab symposium at EASD 2025 in Vienna. The event was well attended, well presented and discussed, and is now availabe online:
https://t.co/8Y57HAIcLd
Thanks to EASD for hosting this #diabeticneuropathy symposium.